Bone and Joint Infection
Conditions
Brief summary
The aim of this study is to describe the bone or joint infection due to Pseudomonas aeruginosa in patients having implant.
Interventions
OTHERBone or joint infection due to Pseudomonas aeruginosa
Description of bone or joint infection on implant due to Pseudomonas aeruginosa
Sponsors
Hospices Civils de Lyon
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Inclusion criteria
* patients having BJI on implant caused by Pseudomonas aeruginosa
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Description and rate of bone or joint infection on implant caused due to Pseudomonas aeruginosa | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption) | Description of the type of infection due to P. aeruginosa : patients and type of implant, profile of the bacterium, medical and chirurgical treatment, rate |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of adverse events occurring under medical treatment against Pseudomonas aeruginosa | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption) | description of adverse events occurring under medical treatment against Pseudomonas aeruginosa in BJI |
| Rate of Treatment Failure | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption) | Treatment failure is defined by local clinical and/or microbiological relapse; and/or need for additional surgery; death of septic origin |
Countries
France
Outcome results
None listed